Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment

被引：0
|
作者：
So, H. [1 ]
Kim, H. [1 ]
Oh, G. [1 ]
Yang, S. [2 ]
Lee, S. [3 ]
Moon, S. [4 ]
Kwon, K. [5 ]
Park, R. [6 ]
机构：
[1] Wonkwang Univ, Sch Med, Iksan, Jeonbuk, South Korea
[2] Wonkwang Univ, Sch Med, Internal Med, Iksan, Jeonbuk, South Korea
[3] Wonkwang Univ, Sch Med, Thorac Surg, Iksan, Jeonbuk, South Korea
[4] Wonkwang Univ, Sch Med, Radiat Oncol, Iksan, Jeonbuk, South Korea
[5] Wonkwang Univ, Coll Korean Med, Physioloy, Iksan, Jeonbuk, South Korea
[6] Wonkwang Univ, Sch Med, Microbiol, Iksan, Jeonbuk, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50633-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
720
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [1] Augmentation of NAD+ by NQO1 Activation Attenuates Cisplatin-Mediated Hearing Impairment
    Yang, Seihoon
    Moon, Sun-Rock
    Kwon, Kang-Beom
    So, Hong-Seob
    Lee, Sam-Youn
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S539 - S539
  • [2] Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment
    Sei-hoon, Y.
    Kwon, K. B.
    So, H. S.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E62 - E62
  • [3] Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment
    Yang, S-H.
    Kwon, K-B. K.
    So, H-S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S136 - S137
  • [4] Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment
    Yang, S.
    Oh, G. S.
    Kwon, K. B.
    Park, R. K.
    Lee, S. Y.
    Moon, S. R.
    So, H. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 55 - 55
  • [5] Augmentation of NAD+ by NQO1 attenuates cisplatin-mediated hearing impairment
    Kim, H-J
    Oh, G-S
    Shen, A.
    Lee, S-B
    Choe, S-K
    Kwon, K-B
    Lee, S.
    Seo, K-S
    Kwak, T. H.
    Park, R.
    So, H-S
    CELL DEATH & DISEASE, 2014, 5 : e1292 - e1292
  • [6] Augmentation of NAD+ by NQO1 attenuates cisplatin-mediated hearing impairment
    H-J Kim
    G-S Oh
    A Shen
    S-B Lee
    S-K Choe
    K-B Kwon
    S Lee
    K-S Seo
    T H Kwak
    R Park
    H-S So
    Cell Death & Disease, 2014, 5 : e1292 - e1292
  • [7] Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice
    Oh, Gi-Su
    Kim, Hyung-Jin
    Choi, Jae-Hyuck
    Shen, AiHua
    Choe, Seong-Kyu
    Karna, Anzani
    Lee, Seung Hoon
    Jo, Hyang-Jeong
    Yang, Sei-Hoon
    Kwak, Tae Hwan
    Lee, Chul-Ho
    Park, Raekil
    So, Hong-Seob
    KIDNEY INTERNATIONAL, 2014, 85 (03) : 547 - 560
  • [8] Augmentation of cellular NAD+ by NQO1 enzymatic action improves age-related hearing impairment
    Kim, Hyung-Jin
    Cao, Wa
    Oh, Gi-Su
    Lee, SeungHoon
    Shen, AiHua
    Khadka, Dipendra
    Lee, Su-Bin
    Sharma, Subham
    Kim, Seon Young
    Choe, Seong-Kyu
    Kwak, Tae Hwan
    Kim, Jin-Man
    Park, Raekil
    So, Hong-Seob
    AGING CELL, 2019, 18 (05)
  • [9] Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD+ levels
    Ahmad, Saeed Nazari Soltan
    Rashtchizadeh, Nadereh
    Argani, Hassan
    Roshangar, Leila
    Haghjo, Amir Ghorbani
    Sanajou, Davoud
    Panah, Fatemeh
    Jigheh, Zahra Ashrafi
    Dastmalchi, Siavoush
    Mesgari-Abbasi, Mehran
    FREE RADICAL RESEARCH, 2018, 52 (07) : 808 - 817
  • [10] β-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation
    Lu, Christopher Y.
    KIDNEY INTERNATIONAL, 2014, 85 (03) : 495 - 497
12345